177 related articles for article (PubMed ID: 9591600)
1. Use of stabilized technetium-99m-exametazime for radiolabeling leukocytes.
Hung JC; Chowdhury S; Mullan BP
J Nucl Med; 1998 May; 39(5):912-7. PubMed ID: 9591600
[TBL] [Abstract][Full Text] [Related]
2. Effects of methylene blue stabilizer on in vitro viability and chemotaxis of 99mTc-exametazime-labeled leukocytes.
Hung JC; Iverson BC; Toulouse KA; Mahoney DW
J Nucl Med; 2002 Jul; 43(7):928-32. PubMed ID: 12097465
[TBL] [Abstract][Full Text] [Related]
3. Chemotaxis, viability, and labeling stability of leukocytes labeled with (99m)Tc-exametazime stabilized with methylene blue.
Roca M; Iglesias F; García V; Armero F; Díaz MC
J Nucl Med; 2001 Mar; 42(3):505-8. PubMed ID: 11337530
[TBL] [Abstract][Full Text] [Related]
4. Radiolabelled mixed leukocytes and pure granulocytes with stabilized 99Tcm-exametazime.
Hung JC; Chowdhury S; Mahoney DW; Mullan BP
Nucl Med Commun; 1998 Oct; 19(10):981-7. PubMed ID: 10234678
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution and radiation dosimetry of stabilized 99mTc-exametazine-labeled leukocytes in normal subjects.
Robins PD; Salazar I; Forstrom LA; Mullan BP; Hung JC
J Nucl Med; 2000 May; 41(5):934-40. PubMed ID: 10809211
[TBL] [Abstract][Full Text] [Related]
6. [Stabilization of 99m Tc-HMPAO with methylene blue: its use in leukocyte labelling)].
García Seguí V; Roca Engroñat M; Armero Muñoz F; Iglesias Allende F; Gomes Barreto de Mélo V; Martin-Comín J
Rev Esp Med Nucl; 1998; 17(4):261-4. PubMed ID: 9721341
[TBL] [Abstract][Full Text] [Related]
7. Are leukocytes labeled with stabilized 99mTc-HMPAO becoming activated during labeling?
Grüning T; Franke WG
J Nucl Med; 2001 Apr; 42(4):685-6. PubMed ID: 11337560
[No Abstract] [Full Text] [Related]
8. Stability of stabilized 99mTc-D,L-HMPAO stored in vials and syringes.
Del Carmen Plancha-Mansanet M; Caballero-Calabuig E; Félix-Fontestad J; Reyes-Ojeda MD; Sopena-Novales P; Abreu-Sánchez P; Del Carmen Cano-Terol M; Sopena-Monforte R
J Nucl Med Technol; 2008 Dec; 36(4):213-6. PubMed ID: 19008289
[TBL] [Abstract][Full Text] [Related]
9. In vitro studies of leukocyte labeling with technetium-99m.
Uchida T; Vincent PC
J Nucl Med; 1976 Aug; 17(8):730-6. PubMed ID: 932819
[TBL] [Abstract][Full Text] [Related]
10. Efficient site-specific radiolabeling of a modified C2A domain of synaptotagmin I with [99mTc(CO)3]+: a new radiopharmaceutical for imaging cell death.
Tavaré R; Torres Martin De Rosales R; Blower PJ; Mullen GE
Bioconjug Chem; 2009 Nov; 20(11):2071-81. PubMed ID: 19874007
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte labeling with technetium-99m tin colloids.
Mock BH; English D
J Nucl Med; 1987 Sep; 28(9):1471-7. PubMed ID: 3625299
[TBL] [Abstract][Full Text] [Related]
12. [99mTc-HMPAO labeling of leukocytes and thrombocytes. Characteristics and diagnostic consequences].
Becker W; Börner W
Rofo; 1988 Jan; 148(1):69-74. PubMed ID: 2829311
[TBL] [Abstract][Full Text] [Related]
13. Technetium-labelled autologous lymphocytes: clinical protocol for radiolabelling using a high concentration and low volume of 99Tcm-exametazime.
Sampson CB; Goffin E
Nucl Med Commun; 1991 Oct; 12(10):875-8. PubMed ID: 1792022
[TBL] [Abstract][Full Text] [Related]
14. 99Tcm-exametazime-labelled leucocytes: effect of volume and concentration of exametazime on labelling efficiency, and clinical protocol for high efficiency multi-dose radiolabelling.
Sampson CB; Solanki C; Barber RW
Nucl Med Commun; 1991 Aug; 12(8):719-23. PubMed ID: 1780111
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the stability of (99m)Tc-ECD and stabilized (99m)Tc-HMPAO stored in syringes.
Koslowsky IL; Brake SE; Bitner SJ
J Nucl Med Technol; 2001 Dec; 29(4):197-200. PubMed ID: 11756532
[TBL] [Abstract][Full Text] [Related]
16. New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.
Pijarowska-Kruszyna J; Karczmarczyk U; Jaroń AW; Laszuk E; Radzik M; Garnuszek P; Mikołajczak R
Nucl Med Rev Cent East Eur; 2017; 20(2):88-94. PubMed ID: 28555448
[TBL] [Abstract][Full Text] [Related]
17. A trial study of leukocyte labeling with stabilized Tc-99m D,L-HMPAO by methylene blue and sodium phosphate buffer.
Kao CH; Huang WT; Wey SP; Changlai SP; Liao KK; Tsai CS
Appl Radiat Isot; 1999 Mar; 50(3):513-9. PubMed ID: 10070711
[TBL] [Abstract][Full Text] [Related]
18. An in vitro study to compare 99mTc-stannous colloids and 99mTc-HMPAO for labelling human leukocytes.
Capriotti G; D'Alessandria C; Garin E; Weber E; Devillers A; Lehmann K; Corsetti F; Lecloirec J; Meller J; Becker W; Moisan A; Signore A
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):229-36. PubMed ID: 15499297
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-HM-PAO: a single dosis preparation for blood cell.
Piera C; Pavía A; Catafau A; Muxí A; Lomeña F; Pons F
Prog Clin Biol Res; 1990; 355():115-8. PubMed ID: 2281092
[No Abstract] [Full Text] [Related]
20. Factors affecting the labeling efficiency and stability of technetium-99m-labeled glucoheptonate.
Zbrzeznj DJ; Khan RA
Am J Hosp Pharm; 1981 Oct; 38(10):1499-502. PubMed ID: 7294045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
